Close Menu
InfoQuest Network
  • News
  • World
    • United States
    • Canada
    • Europe
    • Asia
    • Latin America
    • Australia
    • Africa
  • Politics
  • Business
    • Personal Finance
    • Finance
    • Markets
    • Startup
    • Investing
    • Innovation
    • Billionaires
    • Crypto
  • Tech
  • Lifestyle
  • Sports
  • Travel
  • More
    • Science
    • Entertainment
    • Health & Wellness
    • Immigration
Trending

Smith Hits Hard with Injured Finger

July 5, 2025

Montreal Comiccon Might Benefit from U.S. Trade War, Says Spokesperson

July 5, 2025

Texas Flood Underscores ‘Neglected’ Weather Alert System Trump Plans to Modernize

July 5, 2025
Facebook X (Twitter) Instagram
Smiley face Weather     Live Markets
  • Newsletter
  • Advertise
Facebook X (Twitter) Instagram YouTube
InfoQuest Network
  • News
  • World
    • United States
    • Canada
    • Europe
    • Asia
    • Latin America
    • Australia
    • Africa
  • Politics
  • Business
    • Personal Finance
    • Finance
    • Markets
    • Startup
    • Investing
    • Innovation
    • Billionaires
    • Crypto
  • Tech
  • Lifestyle
  • Sports
  • Travel
  • More
    • Science
    • Entertainment
    • Health & Wellness
    • Immigration
InfoQuest Network
  • News
  • World
  • Politics
  • Business
  • Finance
  • Entertainment
  • Health & Wellness
  • Lifestyle
  • Technology
  • Travel
  • Sports
  • Personal Finance
  • Billionaires
  • Crypto
  • Innovation
  • Investing
  • Markets
  • Startup
  • Immigration
  • Science
Home»Business»Markets»Is Abbott Stock at $105 a Smart Investment Choice After Strong Q2 Performance?
Markets

Is Abbott Stock at $105 a Smart Investment Choice After Strong Q2 Performance?

News RoomBy News RoomJuly 27, 20240 ViewsNo Comments2 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email Reddit Telegram WhatsApp

Abbott recently reported its Q2 results, exceeding expectations with revenue of $10.4 billion and earnings of $1.14 per share. Despite this, the stock performance has been lackluster, with little change from $110 in early 2021 to around $107 now. In comparison, the S&P 500 has seen a 45% increase over the same period. Returns for ABT stock were 29% in 2021, -22% in 2022, and 0% in 2023. The company has underperformed the S&P in 2022 and 2023.

Consistently beating the S&P 500 has been difficult for individual stocks in recent years, including heavyweights in the Health Care sector and megacap stars. The Trefis High Quality Portfolio, however, has outperformed the S&P 500 each year over the same period. Given the uncertain macroeconomic environment, there is a question of whether ABT will underperform the S&P over the next 12 months or see a strong jump. Valuation analysis suggests ABT stock has some room for growth, estimated at $119 per share.

In Q2, Abbott saw revenue growth of 4% y-o-y, with a 10.2% increase in medical device segment sales, 3.5% growth in nutrition sales, and a 0.6% rise in established pharmaceuticals revenue. Diagnostics sales saw a 5.3% decline due to lower demand for COVID-19 testing, but excluding these tests, sales were up 5.9%. Diabetes sales within the medical devices segment were up 15.8%. Abbott expects its total 2024 revenue to rise 9.5-10% on an organic basis with an expansion of margins and a 5.6% increase in adjusted pre-tax income in Q2.

Kangen Water

Overall, Abbott’s results were upbeat, with margin expansion and an upward revision for its full-year outlook. The stock has risen around 5% in the last five days, indicating potential room for further growth. With a valuation suggesting over 10% upside from current levels, Abbott appears poised for growth. In comparison with its peers, it will be interesting to see how Abbott continues to perform in the competitive market.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related News

Three Dividend Stocks Offering More than 7% Returns in Any Market

August 9, 2024

Reflections on 2008: Navigating a Challenging Economy with Ford

August 9, 2024

Can Baidu’s AI Innovations Drive Stock Growth After Q2 Results?

August 8, 2024

Anticipating the Outcome of Wheaton Precious Metals’ Q2 Results

August 8, 2024

What Factors are Contributing to the Decline in Nintendo Stock Prices?

August 8, 2024

Markets Aiming for Back-to-Back Winning Days

August 8, 2024
Add A Comment
Leave A Reply Cancel Reply

Top News

Montreal Comiccon Might Benefit from U.S. Trade War, Says Spokesperson

July 5, 2025

Texas Flood Underscores ‘Neglected’ Weather Alert System Trump Plans to Modernize

July 5, 2025

Saints Star Alvin Kamara Requests a Re-Do After Disastrous First Pitch at Cubs-Cardinals Game

July 5, 2025

Subscribe to Updates

Get the latest news and updates directly to your inbox.

Advertisement
Kangen Water
InfoQuest Network
Facebook X (Twitter) Instagram YouTube
  • Home
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 Info Quest Network. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.